Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia.
Sci Transl Med. 2022 Oct 26;14(668):eabq3010. doi: 10.1126/scitranslmed.abq3010. Epub 2022 Oct 26.
Sci Transl Med. 2022.
PMID: 36288281
Clinical Trial.
Genome-Edited T Cell Therapies.
Ottaviano G, Qasim W.
Ottaviano G, et al.
Hematol Oncol Clin North Am. 2022 Aug;36(4):729-744. doi: 10.1016/j.hoc.2022.03.006. Epub 2022 Jun 27.
Hematol Oncol Clin North Am. 2022.
PMID: 35773047
Review.
Item in Clipboard
The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.
Ottaviano G, Baird S, Bonney D, Connor P, Cummins M, Evans P, Gibson B, Hough R, Ingham D, Kelly A, Qureshi A, Lancaster D, Moppett J, Norton A, Payne J, Stockley S, Ghorashian S, Amrolia P, Qasim W, Vora A.
Ottaviano G, et al.
Br J Haematol. 2021 Jan;192(2):e42-e44. doi: 10.1111/bjh.17198. Epub 2020 Nov 20.
Br J Haematol. 2021.
PMID: 33216967
Free article.
No abstract available.
Item in Clipboard
Cite
Cite